Cytokinetics, Incorporated
CYTK
$74.13
$0.680.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 42.41% | -7.22% | -8.34% | 12.17% | -8.54% |
| Total Receivables | 257.87% | -61.57% | 882.52% | -78.50% | 317.99% |
| Inventory | 146.75% | -- | -- | -- | -- |
| Prepaid Expenses | 29.10% | -17.99% | 30.63% | -34.96% | 26.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 43.96% | -8.45% | -6.18% | 10.24% | -7.27% |
|
|
|||||
| Total Current Assets | 43.96% | -8.45% | -6.18% | 10.24% | -7.27% |
| Net Property, Plant & Equipment | -3.29% | 1.17% | 1.04% | 4.95% | 1.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.17% | 28.66% | 3.16% | 15.51% | 14.62% |
| Total Assets | 51.13% | -10.60% | -0.84% | 17.21% | -3.04% |
|
|
|||||
| Total Accounts Payable | -16.99% | 10.62% | 1.15% | 36.09% | 16.40% |
| Total Accrued Expenses | 11.62% | -17.31% | 35.12% | 17.81% | 20.66% |
| Short-term Debt | 3.72% | -4.82% | 84.02% | -3.98% | 50.43% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -26.41% | 9.08% | 58.97% | 11.60% | 4.46% |
| Total Finance Division Other Current Liabilities | -51.62% | 88.15% | 51.25% | -67.08% | -81.21% |
| Total Other Current Liabilities | -51.62% | 88.15% | 51.25% | -67.08% | -81.21% |
| Total Current Liabilities | -8.91% | -1.61% | 42.43% | 8.45% | -17.94% |
|
|
|||||
| Total Current Liabilities | -8.91% | -1.61% | 42.43% | 8.45% | -17.94% |
| Long-Term Debt | -0.01% | 0.29% | 4.62% | 39.92% | 10.75% |
| Short-term Debt | 3.72% | -4.82% | 84.02% | -3.98% | 50.43% |
| Capital Leases | -2.67% | -2.53% | -2.43% | -0.34% | -2.05% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.37% | 3.43% | 2.72% | 2.89% | 2.58% |
| Total Liabilities | -0.10% | 0.76% | 6.46% | 22.79% | 4.17% |
|
|
|||||
| Common Stock & APIC | 29.78% | 1.46% | 1.58% | 5.84% | 1.30% |
| Retained Earnings | -5.38% | -5.91% | -5.54% | -10.21% | -4.69% |
| Treasury Stock & Other | -137.34% | -355.87% | 1,752.94% | 121.52% | -110.23% |
| Total Common Equity | 79.01% | -25.31% | -26.58% | -41.33% | -38.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 79.01% | -25.31% | -26.58% | -41.33% | -38.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 79.01% | -25.31% | -26.58% | -41.33% | -38.40% |
|
|
|||||